Well darn! The bear got the ball back and away it went d o w n …
But the bull still has supports below at the 79 & 89 MAs. Let’s see if the bull can kick this ball back up the hill.
Meanwhile, $DMRC is quite busy making it trek back up the cliff it felt down from. Like a steady rock climber, it is going up one anchor at a time. Recent ownership report is showing a roster of big name buyers coming on board. Take a look at names who owned more than 1% of the float:
I’m betting that the high volumes you have been seeing since the big drop are due to accumulation from many big buyers. An interesting perspective, if I’m right about the accumulation, is that the shorts have been manipulated by the bigger fish to stage a sell-off so they can swoop in to buy a boat load. Meanwhile, the shorts are digging themselves deeper into the hole. If the shorts are any wiser, they may start thinking about getting out now before the tsunami of buy orders flood the Digimarc gate.
The beauty of holding Digimarc is that once the adoption of the technology is validated by the big retailers, the value of $DMRC can only go up, up, and up. Why? It is my belief that the progressive adoption of the technology by the rest of the world will start from trickle to a torrid flood that can last a decade. And then a cycle of new items will flood the world along with the setup fees and renewal fees going to Digimarc. This will go on and on until the patent expired. By then, all those who hold $DMRC all the way to the end will be buying mansions and Ferraris. (pardon the cliche!)
Look like $DMRC is a good climber here.
$BIOC gave back part of yesterday gain. But I still think the shorts got it wrong here. An announcement of the prostrate assay for cancer test will change this one around R E A L L Y QUICK!. Think about this, Biocept has been making inroad with the medical insurers to get their products covered; thus, when a more popular test such as prostrate cancer test is introduced by Biocept, it will be almost like a shoe-in for immediate coverage What this mean is that anyone over 50 years of age and received a doctor notice of a high PSA number, they will opt for the Biocept liquid biopsy over a tissue biopsy. Why Biocept? Oh yeah, that is because they are already covered by insurance. Ding! Ding! A note to the shorts- you may think you win this round, but you will be in major pain if you don’t cover soon enough. If there is an announcement that Blue Cross is on board, OMG!
$IBIO, $AKAO, and $ARTH are all consolidating within their range; so there is not much to say but to wait, wait, and wait.
Here is another wisdom from Warren Buffett:
“Successful Investing takes time, discipline and patience. No matter how great the talent or effort, some things just take time: You can’t produce a baby in one month by getting nine women pregnant.”
Main port: DMRC, IBIO, BIOC, AKAO Trading port: ARTH
My 2 cents
From my camera (click on photo to see image at 100%)
Categories: Daily trading Journal